Discover the world's scientific knowledge

With 160+ million publication pages, 25+ million researchers and 1+ million questions, this is where everyone can access science

You can use AND, OR, NOT, "" and () to specify your search.

PublicationsAuthorsQuestions
Stress echocardiography and left atrial strain as a method to assess the likelihood of developing atrial fibrillation in patients undergoing anticancer therapy as a manifestation of cardiotoxicity
Article
  • May 2023
  • DOI: 10.1093/eurjpc/zwad125.290
  • ISBN: 2047-4873
  • Martina Samardjieva
    Martina Samardjieva
  • Iana Simova
    Iana Simova
  • M Sirakov
    M Sirakov
  • V Petrusheva
    V Petrusheva
  • N.Chilingirova
    N.Chilingirova
Abstract P5-08-17: Monitoring for cardiotoxicity in early breast cancer: an Australian experience
Article
  • Mar 2023
  • DOI: 10.1158/1538-7445.SABCS22-P5-08-17
  • ISBN: 1538-7445
  • Brendan Kirwin
    Brendan Kirwin
  • Lina Pugliano
    Lina Pugliano
  • Sally Baron Hay
    Sally Baron Hay
Anthracycline-induced cardiotoxicity – are we about to clear this hurdle?
Article
  • Feb 2023
  • DOI: 10.1016/j.ejca.2023.02.019
  • ISBN: 1879-0852
  • Wolfram C. M. Dempke
    Wolfram C. M. Dempke
  • Rafal J. Zielinski
    Rafal J. Zielinski
  • Christina Winkler
    Christina Winkler
  • Sandra Silberman
    Sandra Silberman
  • Susanne Reuther
    Susanne Reuther
Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure
Article
  • Jan 2023
  • DOI: 10.1007/s11897-023-00587-0
  • ISBN: 1546-9549
  • Alex R. Ritter
    Alex R. Ritter
  • Cooper Quartermaine
    Cooper Quartermaine
  • Jovan Pierre-Charles
    Jovan Pierre-Charles
  • Suryakumar Balasubramanian
    Suryakumar Balasubramanian
  • Pejman Raeisi-Giglou
    Pejman Raeisi-Giglou
PREVENTION AND MANAGEMENT OF ANTHRACYCLINE INDUCED CARDIOTOXICITY: A REVIEW
Article
  • Nov 2022
  • DOI: 10.1016/j.hsr.2022.100070
  • Ranjeet Kumar
    Ranjeet Kumar
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
Article
  • Sep 2022
  • DOI: 10.1002/14651858.CD014638.pub2
  • ISBN: 1469-493X
  • Esmée C. de Baat
    Esmée C. de Baat
  • Renée L Mulder
    Renée L Mulder
  • Saro H. Armenian
    Saro H. Armenian
  • Elizabeth AM Feijen
    Elizabeth AM Feijen
  • Heynric B Grotenhuis
    Heynric B Grotenhuis
An artificial intelligence approach for predicting cardiotoxicity in breast cancer patients receiving anthracycline
Article
  • Oct 2022
  • DOI: 10.1007/s00204-022-03341-y
  • ISBN: 1432-0738
  • Wei-Ting Chang
    Wei-Ting Chang
  • Chung-Feng Liu
    Chung-Feng Liu
  • Yin-Hsun Feng
    Yin-Hsun Feng
  • Chia-Te Liao
    Chia-Te Liao
  • Jhi-Joung Wang
    Jhi-Joung Wang
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies
Article
  • Jun 2021
  • DOI: 10.1007/s10549-021-06280-x
  • ISBN: 1573-7217
  • Naomi Dempsey
    Naomi Dempsey
  • Amanda Rosenthal
    Amanda Rosenthal
  • Nitika Dabas
    Nitika Dabas
  • Yana Kropotova
    Yana Kropotova
  • Marc E. Lippman
    Marc E. Lippman
Cardiotoxicity after Cancer Treatment: Comparing Clinical Practice with Guidelines
Article
  • Aug 2018
  • DOI: 10.1016/j.cardfail.2018.07.027
  • ISBN: 1071-9164
  • Robyn A Clark
    Robyn A Clark
  • Tania S. Marin
    Tania S. Marin
  • John J Atherton
    John J Atherton
  • Julie Bradley
    Julie Bradley
  • J. Foote
    J. Foote
The role of angiotensin signalling in anthracycline-induced cardiotoxicity
Article
  • Oct 2021
  • DOI: 10.1093/eurheartj/ehab724.2882
  • ISBN: 0195-668X
  • Simon G. Findlay
    Simon G. Findlay
  • C.J Plummer
    C.J Plummer
  • Ruth Plummer
    Ruth Plummer
  • J H Gill
    J H Gill
1
2
3
4
5
10
App Store
Get it on Google Play
Company
About us
News
Careers
Support
Help Center
Business solutions
Advertising
Recruiting
© 2008-2023 ResearchGate GmbH. All rights reserved.
  • Terms
  • Privacy
  • Copyright
  • Imprint
Join for free
Log in